SLC2A4 and hyperlipidemia: Further research into the role of AMPK as a potential therapeutic target for cardiomyopathy, diabetes, and hyperlipidemia is warranted, given its presence in the signal transduction pathway that ultimately leads to the translocation of GLUT4 to the sarcolemma[92].